| Product Code: ETC13056916 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import of paediatric vaccines in Ivory Coast in 2024 saw significant contributions from top exporting countries such as Italy, France, Denmark, India, and Argentina. With a moderate concentration level indicated by the Herfindahl-Hirschman Index (HHI) in 2024, the market remains competitive. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a healthy 4.83%, while the growth rate from 2023 to 2024 was 1.73%, reflecting steady progress in meeting the pediatric vaccination needs in the country.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cote D'Ivore Paediatric Vaccine Market Overview |
3.1 Cote D'Ivore Country Macro Economic Indicators |
3.2 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume, 2022 & 2032F |
3.3 Cote D'Ivore Paediatric Vaccine Market - Industry Life Cycle |
3.4 Cote D'Ivore Paediatric Vaccine Market - Porter's Five Forces |
3.5 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume Share, By Vaccine Type, 2022 & 2032F |
3.7 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.8 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Cote D'Ivore Paediatric Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government focus on immunization programs and healthcare infrastructure development |
4.2.2 Growing awareness about the importance of pediatric vaccines among parents and healthcare professionals |
4.2.3 Rising incidence of infectious diseases and outbreaks driving the demand for pediatric vaccines |
4.3 Market Restraints |
4.3.1 High cost associated with the development and distribution of vaccines |
4.3.2 Limited access to healthcare services in remote areas impacting vaccine coverage |
4.3.3 Vaccine hesitancy and misinformation leading to lower vaccination rates |
5 Cote D'Ivore Paediatric Vaccine Market Trends |
6 Cote D'Ivore Paediatric Vaccine Market, By Types |
6.1 Cote D'Ivore Paediatric Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume, By Live Attenuated, 2022 - 2032F |
6.1.4 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume, By Inactivated, 2022 - 2032F |
6.1.5 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume, By Conjugate, 2022 - 2032F |
6.1.6 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume, By Recombinant, 2022 - 2032F |
6.2 Cote D'Ivore Paediatric Vaccine Market, By Vaccine Type |
6.2.1 Overview and Analysis |
6.2.2 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume, By MMR Vaccine, 2022 - 2032F |
6.2.3 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume, By Polio Vaccine, 2022 - 2032F |
6.2.4 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume, By Pneumococcal, 2022 - 2032F |
6.2.5 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume, By Hepatitis B, 2022 - 2032F |
6.3 Cote D'Ivore Paediatric Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume, By Intramuscular, 2022 - 2032F |
6.3.3 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume, By Subcutaneous, 2022 - 2032F |
6.3.4 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume, By Oral, 2022 - 2032F |
6.3.5 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume, By Intravenous, 2022 - 2032F |
6.4 Cote D'Ivore Paediatric Vaccine Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume, By Infants, 2022 - 2032F |
6.4.3 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume, By Toddlers, 2022 - 2032F |
6.4.4 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume, By Adolescents, 2022 - 2032F |
6.4.5 Cote D'Ivore Paediatric Vaccine Market Revenues & Volume, By Newborns, 2022 - 2032F |
7 Cote D'Ivore Paediatric Vaccine Market Import-Export Trade Statistics |
7.1 Cote D'Ivore Paediatric Vaccine Market Export to Major Countries |
7.2 Cote D'Ivore Paediatric Vaccine Market Imports from Major Countries |
8 Cote D'Ivore Paediatric Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates among children under 5 years old |
8.2 Number of public-private partnerships established to improve vaccine accessibility |
8.3 Rate of adoption of new and advanced pediatric vaccines in the market |
9 Cote D'Ivore Paediatric Vaccine Market - Opportunity Assessment |
9.1 Cote D'Ivore Paediatric Vaccine Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Cote D'Ivore Paediatric Vaccine Market Opportunity Assessment, By Vaccine Type, 2022 & 2032F |
9.3 Cote D'Ivore Paediatric Vaccine Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.4 Cote D'Ivore Paediatric Vaccine Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Cote D'Ivore Paediatric Vaccine Market - Competitive Landscape |
10.1 Cote D'Ivore Paediatric Vaccine Market Revenue Share, By Companies, 2025 |
10.2 Cote D'Ivore Paediatric Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here